Two different experimental mRNA vaccines have ‘now shown remarkable effectiveness of about 95 percent in preventing COVID-19 infection in adults,’ stated the U.S. Food and Drug Administration (FDA) leadership on January 4, 2020.
Read More

Two different experimental mRNA vaccines have ‘now shown remarkable effectiveness of about 95 percent in preventing COVID-19 infection in adults,’ stated the U.S. Food and Drug Administration (FDA) leadership on January 4, 2020.
Read More